Speed to market is the competitive edge for drug development. Successful medicines generate $3 to $10M/day in revenue. Shaving just 30 days off the discovery process can increase revenue by as much as $300M. Climb, is a global cloud informatics platform that improves lab efficiencies and speeds time to market. Backed and vetted by the NIH, Climb is currently being used in over 30 institutions, including global pharmaceutical companies, public biotechs, and in a Nobel Laureates laboratory at UCSF.